{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:36:28Z","timestamp":1794638188268,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The integrated stress response manifests with the phosphorylation of eukaryotic initiation factor 2\u03b1 (eIF2\u03b1) on serine residue 51 and plays a major role in the adaptation of cells to endoplasmic reticulum stress in the initiation of autophagy and in the ignition of immune responses. Here, we report that lysosomotropic agents, including azithromycin, chloroquine, and hydroxychloroquine, can trigger eIF2\u03b1 phosphorylation in vitro (in cultured human cells) and, as validated for hydroxychloroquine, in vivo (in mice). Cells bearing a non-phosphorylatable eIF2\u03b1 mutant (S51A) failed to accumulate autophagic puncta in response to azithromycin, chloroquine, and hydroxychloroquine. Conversely, two inhibitors of eIF2\u03b1 dephosphorylation, nelfinavir and salubrinal, enhanced the induction of such autophagic puncta. Altogether, these results point to the unexpected capacity of azithromycin, chloroquine, and hydroxychloroquine to elicit the integrated stress response.<\/jats:p>","DOI":"10.1038\/s41419-020-03324-w","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:03:40Z","timestamp":1610049820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response"],"prefix":"10.1038","volume":"12","author":[{"given":"Ai-Ling","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1682-9222","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"3324_CR1","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret, P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 56, 105949 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"3324_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00154741","volume":"70","author":"K Holopigian","year":"1988","unstructured":"Holopigian, K., Snow, J., Seiple, W. & Siegel, I. Variability of the pattern electroretinogram. Doc. Ohthalmol. 70, 103\u2013115 (1988).","journal-title":"Doc. Ohthalmol."},{"key":"3324_CR3","doi-asserted-by":"publisher","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","volume":"34","author":"P Gautret","year":"2020","unstructured":"Gautret, P. et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med. Infect. Dis. 34, 101663 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"3324_CR4","doi-asserted-by":"publisher","unstructured":"Lagier, J. C. et al. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine\/azithromycin and other regimens in Marseille, France: a retrospective analysis. Travel Med. Infect. Dis. 101791, https:\/\/doi.org\/10.1016\/j.tmaid.2020.101791 (2020).","DOI":"10.1016\/j.tmaid.2020.101791"},{"key":"3324_CR5","doi-asserted-by":"publisher","unstructured":"Mikami, T. et al. Risk factors for mortality in patients with COVID-19 in New York City. J. Gen. Intern. Med. https:\/\/doi.org\/10.1007\/s11606-020-05983-z (2020).","DOI":"10.1007\/s11606-020-05983-z"},{"key":"3324_CR6","doi-asserted-by":"publisher","first-page":"m1849","DOI":"10.1136\/bmj.m1849","volume":"369","author":"W Tang","year":"2020","unstructured":"Tang, W. et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ 369, m1849 (2020).","journal-title":"BMJ"},{"key":"3324_CR7","doi-asserted-by":"publisher","unstructured":"Boulware, D. R. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2016638 (2020).","DOI":"10.1056\/NEJMoa2016638"},{"key":"3324_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s40261-020-00927-1","volume":"40","author":"S Das","year":"2020","unstructured":"Das, S., Bhowmick, S., Tiwari, S. & Sen, S. An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19). Clin. Drug Investig. 40, 591\u2013601 (2020).","journal-title":"Clin. Drug Investig."},{"key":"3324_CR9","doi-asserted-by":"publisher","first-page":"E734","DOI":"10.1503\/cmaj.200647","volume":"192","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis. CMAJ 192, E734\u2013E744 (2020).","journal-title":"CMAJ"},{"key":"3324_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"KD Rainsford","year":"2015","unstructured":"Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M. & Kean, W. F. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23, 231\u2013269 (2015).","journal-title":"Inflammopharmacology"},{"key":"3324_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier, E. & Dorner, T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat. Rev. Rheumatol. 16, 155\u2013166 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"3324_CR12","first-page":"1038","volume":"23","author":"G Weissmann","year":"1964","unstructured":"Weissmann, G. Labilization and stabilization of lysosomes. Fed. Proc. 23, 1038\u20131044 (1964).","journal-title":"Fed. Proc."},{"key":"3324_CR13","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/0006-2952(71)90196-1","volume":"20","author":"LJ Ignarro","year":"1971","unstructured":"Ignarro, L. J. Effects of anti-inflammatory drugs on the stability of rat liver lysosomes in vitro. Biochem. Pharmacol. 20, 2847\u20132860 (1971).","journal-title":"Biochem. Pharmacol."},{"key":"3324_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF01969103","volume":"25","author":"O Carevic","year":"1988","unstructured":"Carevic, O. & Djokic, S. Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. Agents Actions 25, 124\u2013131 (1988).","journal-title":"Agents Actions"},{"key":"3324_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2016.12.021","volume":"117","author":"OF Kuzu","year":"2017","unstructured":"Kuzu, O. F., Toprak, M., Noory, M. A. & Robertson, G. P. Effect of lysosomotropic molecules on cellular homeostasis. Pharmacol. Res. 117, 177\u2013184 (2017).","journal-title":"Pharmacol. Res."},{"key":"3324_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2174\/1389200218666170925125940","volume":"18","author":"S Pisonero-Vaquero","year":"2017","unstructured":"Pisonero-Vaquero, S. & Medina, D. L. Lysosomotropic drugs: pharmacological tools to study lysosomal function. Curr. Drug Metab. 18, 1147\u20131158 (2017).","journal-title":"Curr. Drug Metab."},{"key":"3324_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrs.2015.04.006","volume":"99","author":"D Ploper","year":"2015","unstructured":"Ploper, D. & De Robertis, E. M. The MITF family of transcription factors: role in endolysosomal biogenesis, Wnt signaling, and oncogenesis. Pharmacol. Res. 99, 36\u201343 (2015).","journal-title":"Pharmacol. Res."},{"key":"3324_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0014-4800(80)90015-5","volume":"33","author":"AM Wisner-Gebhart","year":"1980","unstructured":"Wisner-Gebhart, A. M., Brabec, R. K. & Gray, R. H. Morphometric studies of chloroquine-induced changes in hepatocytic organelles in the rat. Exp. Mol. Pathol. 33, 144\u2013152 (1980).","journal-title":"Exp. Mol. Pathol."},{"key":"3324_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","volume":"25","author":"P Boya","year":"2005","unstructured":"Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025\u20131040 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"3324_CR20","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1172\/JCI46095","volume":"121","author":"M Renna","year":"2011","unstructured":"Renna, M. et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J. Clin. Investig. 121, 3554\u20133563 (2011).","journal-title":"J. Clin. Investig."},{"key":"3324_CR21","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1038\/sj.onc.1206622","volume":"22","author":"P Boya","year":"2003","unstructured":"Boya, P. et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22, 3927\u20133936, (2003).","journal-title":"Oncogene"},{"key":"3324_CR22","doi-asserted-by":"publisher","DOI":"10.4161\/mco.29911","volume":"1","author":"G Manic","year":"2014","unstructured":"Manic, G., Obrist, F., Kroemer, G., Vitale, I. & Galluzzi, L. Chloroquine and hydroxychloroquine for cancer therapy. Mol. Cell. Oncol. 1, e29911 (2014).","journal-title":"Mol. Cell. Oncol."},{"key":"3324_CR23","doi-asserted-by":"publisher","first-page":"112168","DOI":"10.18632\/oncotarget.21451","volume":"8","author":"G Kroemer","year":"2017","unstructured":"Kroemer, G. & Galluzzi, L. Lysosome-targeting agents in cancer therapy. Oncotarget 8, 112168\u2013112169 (2017).","journal-title":"Oncotarget"},{"key":"3324_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21, 421\u2013438, (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3324_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4161\/cc.8.6.7939","volume":"8","author":"O Kepp","year":"2009","unstructured":"Kepp, O. et al. Viral subversion of immunogenic cell death. Cell Cycle 8, 860\u2013869, https:\/\/doi.org\/10.4161\/cc.8.6.7939 (2009).","journal-title":"Cell Cycle"},{"key":"3324_CR26","doi-asserted-by":"publisher","unstructured":"Johnston, B. P. & McCormick, C. Herpesviruses and the unfolded protein response. viruses 12, https:\/\/doi.org\/10.3390\/v12010017 (2019).","DOI":"10.3390\/v12010017"},{"key":"3324_CR27","doi-asserted-by":"publisher","unstructured":"Rabouw, H. H. et al. Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-020-0759-0 (2020).","DOI":"10.1038\/s41564-020-0759-0"},{"key":"3324_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1073\/pnas.012485299","volume":"99","author":"Z Talloczy","year":"2002","unstructured":"Talloczy, Z. et al. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc. Natl Acad. Sci. USA 99, 190\u2013195 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3324_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280\u2013293 (2010).","journal-title":"Mol. Cell"},{"key":"3324_CR30","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli, M. & Walter, P. The integrated stress response: from mechanism to disease. Science 368, https:\/\/doi.org\/10.1126\/science.aat5314 (2020).","DOI":"10.1126\/science.aat5314"},{"key":"3324_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2642-6","volume":"11","author":"J Humeau","year":"2020","unstructured":"Humeau, J. et al. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) in autophagy. Cell Death Dis. 11, 433 (2020).","journal-title":"Cell Death Dis."},{"key":"3324_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","volume":"33","author":"O Kepp","year":"2015","unstructured":"Kepp, O. et al. eIF2alpha phosphorylation as a biomarker of immunogenic cell death. Semin. Cancer Biol. 33, 86\u201392 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"3324_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","volume":"25","author":"L Bezu","year":"2018","unstructured":"Bezu, L. et al. eIF2alpha phosphorylation is pathognomonic for immunogenic cell death. Cell Death Differ. 25, 1375\u20131393 (2018).","journal-title":"Cell Death Differ."},{"key":"3324_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911622","volume":"12","author":"J Humeau","year":"2020","unstructured":"Humeau, J. et al. Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress. EMBO Mol. Med. 12, e11622 (2020).","journal-title":"EMBO Mol. Med."},{"key":"3324_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/cdd.2009.8","volume":"16","author":"M Uhl","year":"2009","unstructured":"Uhl, M. et al. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ. 16, 991\u20131005 (2009).","journal-title":"Cell Death Differ."},{"key":"3324_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nri.2016.143","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Reply: the complement system is also important in immunogenic cell death. Nat. Rev. Immunol. 17, 143 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"3324_CR37","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/eji.201847632","volume":"48","author":"KA Tappe","year":"2018","unstructured":"Tappe, K. A. et al. Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8(+) T cell proliferation. Eur. J. Immunol. 48, 2042\u20132054 (2018).","journal-title":"Eur. J. Immunol."},{"key":"3324_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/cdd.2013.75","volume":"21","author":"I Martins","year":"2014","unstructured":"Martins, I. et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ. 21, 79\u201391 (2014).","journal-title":"Cell Death Differ."},{"key":"3324_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4161\/cc.8.4.7794","volume":"8","author":"F Madeo","year":"2009","unstructured":"Madeo, F. et al. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals. Cell Cycle 8, 639\u2013642 (2009).","journal-title":"Cell Cycle"},{"key":"3324_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4939-6603-5_3","volume":"1524","author":"L Senovilla","year":"2017","unstructured":"Senovilla, L., Demont, Y., Humeau, J., Bloy, N. & Kroemer, G. Image cytofluorometry for the quantification of ploidy and endoplasmic reticulum stress in cancer cells. Methods Mol. Biol. 1524, 53\u201364 (2017).","journal-title":"Methods Mol. Biol."},{"key":"3324_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1466765","volume":"7","author":"P Giglio","year":"2018","unstructured":"Giglio, P. et al. PKR and GCN2 stress kinases promote an ER stress-independent eIF2alpha phosphorylation responsible for calreticulin exposure in melanoma cells. Oncoimmunology 7, e1466765 (2018).","journal-title":"Oncoimmunology"},{"key":"3324_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.mie.2016.10.022","volume":"587","author":"JM Bravo-San Pedro","year":"2017","unstructured":"Bravo-San Pedro, J. M. et al. High-throughput quantification of GFP-LC3(+) dots by automated fluorescence microscopy. Methods Enzymol. 587, 71\u201386 (2017).","journal-title":"Methods Enzymol."},{"key":"3324_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"3324_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-cancerbio-030518-055835","volume":"3","author":"RM Perera","year":"2019","unstructured":"Perera, R. M., Di Malta, C. & Ballabio, A. MiT\/TFE family of transcription factors, lysosomes, and cancer. Annu. Rev. Cancer Biol. 3, 203\u2013222 (2019).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"3324_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.mie.2019.04.010","volume":"629","author":"L Bezu","year":"2019","unstructured":"Bezu, L., Wu Chuang, A., Humeau, J., Kroemer, G. & Kepp, O. Quantification of eIF2alpha phosphorylation during immunogenic cell death. Methods Enzymol. 629, 53\u201369 (2019).","journal-title":"Methods Enzymol."},{"key":"3324_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ncb3409","volume":"18","author":"P Saftig","year":"2016","unstructured":"Saftig, P. & Haas, A. Turn up the lysosome. Nat. Cell Biol. 18, 1025\u20131027, https:\/\/doi.org\/10.1038\/ncb3409 (2016).","journal-title":"Nat. Cell Biol."},{"key":"3324_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcell.2019.00114","volume":"7","author":"C Di Malta","year":"2019","unstructured":"Di Malta, C., Cinque, L. & Settembre, C. Transcriptional regulation of autophagy: mechanisms and diseases. Front. Cell Dev. Biol. 7, 114 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"3324_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fonc.2020.00322","volume":"10","author":"PS Acevo-Rodriguez","year":"2020","unstructured":"Acevo-Rodriguez, P. S., Maldonado, G., Castro-Obregon, S. & Hernandez, G. Autophagy regulation by the translation machinery and its implications in cancer. Front. Oncol. 10, 322 (2020).","journal-title":"Front. Oncol."},{"key":"3324_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biocel.2015.01.015","volume":"61","author":"PS Kolb","year":"2015","unstructured":"Kolb, P. S. et al. The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis. Int. J. Biochem. Cell Biol. 61, 45\u201352 (2015).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"3324_CR50","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1073\/pnas.1514076113","volume":"113","author":"A De Gassart","year":"2016","unstructured":"De Gassart, A. et al. An inhibitor of HIV-1 protease modulates constitutive eIF2alpha dephosphorylation to trigger a specific integrated stress response. Proc. Natl Acad. Sci. USA 113, E117\u2013E126 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3324_CR51","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce, M. et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935\u2013939 (2005).","journal-title":"Science"},{"key":"3324_CR52","unstructured":"Pozarowski, P., Grabarek, J. & Darzynkiewicz, Z. Current Protocols in Cell Biology Chapter 18, 18.8.1\u201318.8.33 (John Wiley & Sons, Inc., 2004)."},{"key":"3324_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.361","volume":"7","author":"A Ruiz","year":"2016","unstructured":"Ruiz, A. et al. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis. Cell Death Dis. 7, e2059 (2016).","journal-title":"Cell Death Dis."},{"key":"3324_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.celrep.2016.12.051","volume":"18","author":"R Burikhanov","year":"2017","unstructured":"Burikhanov, R. et al. Chloroquine-inducible Par-4 secretion is essential for tumor cell apoptosis and inhibition of metastasis. Cell Rep. 18, 508\u2013519 (2017).","journal-title":"Cell Rep."},{"key":"3324_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1124\/jpet.117.245639","volume":"365","author":"KP Collins","year":"2018","unstructured":"Collins, K. P., Jackson, K. M. & Gustafson, D. L. Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation. J. Pharmacol. Exp. Therap. 365, 447\u2013459 (2018).","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"3324_CR56","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fphar.2019.00855","volume":"10","author":"X Qiao","year":"2019","unstructured":"Qiao, X. et al. Hydroxychloroquine Improves obesity-associated insulin resistance and hepatic steatosis by regulating lipid metabolism. Front. Pharmacol. 10, 855 (2019).","journal-title":"Front. Pharmacol."},{"key":"3324_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/15548627.2014.984277","volume":"11","author":"O Florey","year":"2015","unstructured":"Florey, O., Gammoh, N., Kim, S. E., Jiang, X. & Overholtzer, M. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy 11, 88\u201399 (2015).","journal-title":"Autophagy"},{"key":"3324_CR58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2014.00388","volume":"5","author":"JR Jheng","year":"2014","unstructured":"Jheng, J. R., Ho, J. Y. & Horng, J. T. ER stress, autophagy, and RNA viruses. Front. Microbiol. 5, 388 (2014).","journal-title":"Front. Microbiol."},{"key":"3324_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01362-6","volume":"17","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. The role of host eIF2alpha in viral infection. Virol. J. 17, 112 (2020).","journal-title":"Virol. J."},{"key":"3324_CR60","doi-asserted-by":"publisher","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","volume":"145","author":"J Andreani","year":"2020","unstructured":"Andreani, J. et al. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb. Pathog. 145, 104228 (2020).","journal-title":"Microb. Pathog."},{"key":"3324_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1074-7613(00)00014-5","volume":"13","author":"S Balachandran","year":"2000","unstructured":"Balachandran, S. et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129\u2013141 (2000).","journal-title":"Immunity"},{"key":"3324_CR62","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4049\/jimmunol.1002240","volume":"186","author":"Q Liang","year":"2011","unstructured":"Liang, Q., Deng, H., Sun, C. W., Townes, T. M. & Zhu, F. Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses. J. Immunol. 186, 1001\u20131010 (2011).","journal-title":"J. Immunol."},{"key":"3324_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15698\/mic2020.05.715","volume":"7","author":"D Carmona-Gutierrez","year":"2020","unstructured":"Carmona-Gutierrez, D. et al. Digesting the crisis: autophagy and coronaviruses. Microb. Cell 7, 119\u2013128 (2020).","journal-title":"Microb. Cell"},{"key":"3324_CR64","doi-asserted-by":"publisher","unstructured":"Bonam, S. R., Muller, S., Bayry, J. & Klionsky, D. J. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy https:\/\/doi.org\/10.1080\/15548627.2020.1779467 (2020).","DOI":"10.1080\/15548627.2020.1779467"},{"key":"3324_CR65","doi-asserted-by":"publisher","unstructured":"Bello-Perez, M., Sola, I., Novoa, B., Klionsky, D. J. & Falco, A. Canonical and noncanonical autophagy as potential targets for COVID-19. Cells https:\/\/doi.org\/10.3390\/cells9071619 (2020).","DOI":"10.3390\/cells9071619"},{"key":"3324_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"3324_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-065X.2007.00567.x","volume":"220","author":"M Obeid","year":"2007","unstructured":"Obeid, M. et al. Ecto-calreticulin in immunogenic chemotherapy. Immunol. Rev. 220, 22\u201334 (2007).","journal-title":"Immunol. Rev."},{"key":"3324_CR68","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/emboj.2009.1","volume":"28","author":"T Panaretakis","year":"2009","unstructured":"Panaretakis, T. et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 28, 578\u2013590 (2009).","journal-title":"EMBO J."},{"key":"3324_CR69","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.4161\/cc.8.23.10191","volume":"8","author":"O Kepp","year":"2009","unstructured":"Kepp, O. et al. Disruption of the PP1\/GADD34 complex induces calreticulin exposure. Cell cycle 8, 3971\u20133977 (2009).","journal-title":"Cell cycle"},{"key":"3324_CR70","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/onc.2010.500","volume":"30","author":"I Martins","year":"2011","unstructured":"Martins, I. et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene 30, 1147\u20131158 (2011).","journal-title":"Oncogene"},{"key":"3324_CR71","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.4078","volume":"22","author":"C Pozzi","year":"2016","unstructured":"Pozzi, C. et al. The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death. Nat. Med. 22, 624\u2013631 (2016).","journal-title":"Nat. Med."},{"key":"3324_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09415-3","volume":"10","author":"P Liu","year":"2019","unstructured":"Liu, P. et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nat. Commun. 10, 1486 (2019).","journal-title":"Nat. Commun."},{"key":"3324_CR73","doi-asserted-by":"publisher","unstructured":"Park, S. J. et al. Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets. mBio https:\/\/doi.org\/10.1128\/mBio.01114-20 (2020).","DOI":"10.1128\/mBio.01114-20"},{"key":"3324_CR74","doi-asserted-by":"publisher","unstructured":"Chen, G. et al. 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB. EMBO Mol. Med. https:\/\/doi.org\/10.15252\/emmm.201910469 (2019).","DOI":"10.15252\/emmm.201910469"},{"key":"3324_CR75","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12865","volume":"504","author":"MT Rosenfeldt","year":"2013","unstructured":"Rosenfeldt, M. T. et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 504, 296\u2013300 (2013).","journal-title":"Nature"},{"key":"3324_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04070-6","volume":"9","author":"L Vera-Ramirez","year":"2018","unstructured":"Vera-Ramirez, L., Vodnala, S. K., Nini, R., Hunter, K. W. & Green, J. E. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat. Commun. 9, 1944 (2018).","journal-title":"Nat. Commun."},{"key":"3324_CR77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbmt.2014.09.025","volume":"21","author":"SV Radhakrishnan","year":"2015","unstructured":"Radhakrishnan, S. V. et al. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transpl. 21, 30\u201338 (2015).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"3324_CR78","doi-asserted-by":"publisher","first-page":"1789284","DOI":"10.1080\/2162402X.2020.1789284","volume":"9","author":"P Liu","year":"2020","unstructured":"Liu, P. et al. Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. Oncoimmunology 9, 1789284 (2020).","journal-title":"Oncoimmunology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03324-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03324-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03324-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:42:58Z","timestamp":1669920178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03324-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["3324"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03324-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.K. and O.K. are cofounders of Samsara Therapeutics, a biotech company developing autophagy inducers for the treatment of aging. The other authors have no relevant conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal experiment was approved by the Gustave Roussy ethics committee with the project number: 24771-2020032413235413, and all procedures were performed in compliance with the governmental and institutional guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"6"}}